Foley Hoag LLP represented Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, in its $1.7 billion acquisition of Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies.
Thermo Fisher Acquisition of Brammer Bio
Authors:
AE
Adrienne Ellman
EM
Earl Mellott
TM
Teresa Martland
MS
Michael Steinke
HIGHLIGHT10 May 2019